4-CMTB
SIGMA/SML0302 - ≥98% (HPLC)
Synonym: 4-Chloro-α-(1-methylethyl)-N-2-thiazolyl-benzeneacetamide
CAS Number: 300851-67-6
Empirical Formula (Hill Notation): C14H15ClN2OS
Molecular Weight: 294.80
MDL Number: MFCD02666163
Linear Formula: C14H15ClN2OS
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C14H15ClN2OS/c1-9(2)12 |
| InChI key | AZYDQCGCBQYFSE-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | CC(C)C(C(=O)Nc1nccs1)c2cc |
| solubility | DMSO: ≥10 mg/mL |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Application: | 4-CMTB has been used as an allosteric agonist for the free fatty acid receptor 2 (FFAR2) in human lung carcinoma (A549) cells for cell viability assay and Influenza A virus (IAV) internalization studies. |
| Biochem/physiol Actions: | 4-CMTB is a phenylacetamide compound that acts as an allosteric modulator for the activity of short-chain fatty acid ligand in the FFA2 receptor. |
| Biochem/physiol Actions: | 4-CMTB is a potent allosteric agonist of FFA2. |
| Biochem/physiol Actions: | 4-CMTB is a potent allosteric agonist of free fatty acid receptor 2 (FFA2). |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H319 |
| Precautionary statements | P301 + P312 + P330 - P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


